Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-adrenoceptor blockade in severe sepsis in rats

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 388-394

  Ackland, Gareth L ^a   Yao, Song T ^b   Rudiger, Alain ^a   Dyson, Alex ^a   Stidwill, Ray ^a   Poputnikov, Dmitry ^a   Singer, Mervyn ^a   Gourine, Alexander V ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adrenoreceptor; Blocker; Cytokines; Inflammation; Sepsis

Indexed keywords

ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CYTOKINE; INTERLEUKIN 18; INTERLEUKIN 6; METOPROLOL; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTOXEMIA; GENE EXPRESSION; HEART PROTECTION; HEART RATE; INFLAMMATION; MALE; MORTALITY; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; RAT; SEPSIS; SURVIVAL; SURVIVAL TIME;

EID: 74949120243     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181c03dfa     Document Type: Article

References (43)

1. Boldt J, Menges T, Kuhn D, et al: Alterations in circulating vasoactive substances in the critically ill-A comparison between survivors and non-survivors. Intensive Care Med 1995; 21:218-225
2. Heilbrunn SM, Shah P, Bristow MR, et al: Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term meto-prolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989; 79: 483-490
3. Herndon DN, Hart DW, Wolf SE, et al: Reversal of catabolism by (3-blockade after severe burns. N Engl J Med 2001 25; 345: 1223-1229
4. Aninat C, Seguin P, Descheemaeker P-N, et al: Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med 2008; 36:848-854
5. Sander O, Welters ID, Foex P, et al: Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 2005; 33:81-88
6. Prass K, Meisel C, Hoeflich C, et al: Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post-stroke T helper cell type 1-like immunos-timulation. J Exp Med 2003; 198:725-736
7. Wang JF, Meissner A, Malek S, et al: Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis. Am J Physiol Heart Circ Physiol 2005; 289:H1577-H1583
8. Lechat P, Packer M, Chalon S, et al: Clinical effects of beta-adrenergic blockade in chronic heart failure: A meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation 1998; 98:1184-1191
9. Prabhu SD, Chandrasekar B, Murray DR, et al: (3-Adrenergic blockade in developing heart failure: Effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000; 101:2103-2109
10. Tracey KJ: Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117:289-296
11. Brealey D, Karyampudi S, Jacques TS, et al: Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failure. Am J Physiol Regul Integr Comp Physiol 2004; 286:R491-R497
12. Rittirsch D, Huber-Lang MS, Flierl MA, et al: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4:31-36
13. Gourine A, Bondar SI, Spyer KM, et al: Beneficial effect of central nervous system B-ad-renoceptor blockade on the failing heart. Circ Res 2008; 102:633-636
14. Rhoden CR, Wellenius GA, Ghelfi E, et al: PM-induced cardiac oxidative stress and dysfunction are mediated by autonomic stimulation. Biochim Biophys Acta 2005; 1725: 305-313
15. Livak KJ, Schmittgen TD: Analyzing realtime PCR data by the comparative C(T) method. Nat Protoc 2008; 3:1101-1108
16. Damas P, Ledoux D, Nys M, et al: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992; 215:356-362
17. Pathan N, Hemingway CA, Alizadeh AA, et al: Role of interleukin-6 in myocardial dysfunction of meningococcal septic shock. Lancet 2004; 363:203-209
18. Kolattukudy PE, Quach T, Bergese S, et al: Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 1998; 152:101-111
19. Wang M, Markel TA, Meldrum DR: Interleu-kin-18 in the heart. Shock 2008; 30:3-10
20. Aronson D, Mittleman MA, Burger AJ: Inter-leukin-6 levels are inversely correlated with heart rate variability in patients with decom-pensated heart failure. J Cardiovasc Electro-physiol 2001; 12:294-300
21. Malave HA, Taylor AA, Nattama J, et al: Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 2003; 123: 716-724
22. Sloan RP, McCreath H, Tracey KJ, et al: RR interval variability is inversely related to inflammatory markers: The CARDIA study. Mol Med 2007; 13:178-184
23. Jeschke MG, Norbury WB, Finnerty CC, et al: Propranolol does not increase inflammation, sepsis, or infectious episodes in severely burned children. J Trauma 2007; 62: 676-681
24. POISE Study Group, Devereaux PJ, et al: Effects of extended-release metoprolol succi-nate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008; 371:1839-1847
25. Johnson JD, Cortez V, Kennedy SL, et al: Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge. Brain Behav Immun 2008; 22:1078-1086
26. Lang CH, Nystrom G, Frost RAL Beta-adrenergic blockade exacerbates sepsis-induced changes in tumor necrosis factor alpha and interleukin-6 in skeletal muscle and is associated with impaired translation initiation. J Trauma 2008; 64:477-486
27. Poldermans D, Boersma E, Bax JJ, et al: The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999; 341:1789-1794
28. Mangano DT, Layug EL, Wallace A, et al: Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med 1996; 335:1713-1720
29. Suzuki T, Morisaki H, Serita R, et al: Infusion of the beta-adrenergic blocker esmolol attenuates myocardial dysfunction in septic rats. Crit Care Med 2005; 33:2294-2301
30. Yang S, Koo DJ, Zhou M, et al: Gut-derived norepinephrine plays a critical role in producing hepatocellular dysfunction during early sepsis. Am J Physiol Gastrointest Liver Physiol 2000; 279:G1274-G1281
31. Kulcsar-Gergely J, Kulcsar A: Metoprolol and propranolol treatment in carbon tetrachlo-ride-induced hepatic injury. Arzneimittelfor-schung 1992; 42:1192-1195
32. Szabó C, Haskó G, Zingarelli B, et al: Isopro-terenol regulates tumour necrosis factor, in-terleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactvity in endotoxae-mia. Immunology 1997; 90:95-100
33. Izeboud CA, Monshouwer M, van Miert AS, et al: The beta-adrenoceptor agonist clen-buterol is a potent inhibitor of the LPS-induced production of TNF-alpha and IL-6 in vitro and in vivo. Inflamm Res 1999; 48: 497-502
34. Izeboud CA, Hoebe KH, Grootendorst AF, et al: Endotoxin-induced liver damage in rats is minimized by beta 2-adrenoceptor stimulation. Inflamm Res 2004; 53:93-99
35. Zhang H, Wang HY, Bassel-Duby R, et al: Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Physiol 2007; 292: H2408-H2416
36. Frangogiannis NG, Mendoza LH, Smith CW, et al: Induction of the synthesis of the CXC chemokine interferon-gamma-inducible pro-tein-10 in experimental canine endotoxemia. Cell Tissue Res 2000; 302:365-376
37. Patterson AJ, Zhu W, Chow A, et al: Protecting the myocardium: A role for the beta2 adrenergic receptor in the heart. Crit Care Med 2004; 32:1041-1048
38. Maurice JP, Hata JA, Shah AS, et al: Enhancement of cardiac function after adeno-viral-mediated in vivo intracoronary beta2-adrenergic receptor gene delivery. J Clin Invest 1999; 104:21-29
39. Ahmet I, Krawczyk M, Heller P, et al: Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy. Circulation 2004; 110: 1083-1090
40. Schmitz D, Wilsenack K, Lendemanns S, et al: Beta-adrenergic blockade during systemic inflammation: Impact on cellular immune functions and survival in a mu-rine model of sepsis. Resuscitation 2007; 72:286-294
41. Berk JL, Hagen JF, Beyer WH, et al: The treatment of endotoxin shock by beta adren-ergic blockade. Ann Surg 1969; 169:74-81
42. Deng J, Muthu K, Gamelli R, et al: Adrener-gic modulation of splenic macrophage cyto-kine release in polymicrobial sepsis. Am J Physiol Cell Physiol 2004; 287:C730-C736
43. Flierl MA, Rittirsch D, Nadeau BA, et al: Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007; 449:721-725